AI Multi-Horizon Analysis
No intraday data available; daily ATR of $10.06 suggests volatility but insufficient granularity for minute-level bias.
Price at $495.63 sits just above 20-day SMA ($494.43) but below MACD signal; volume ~30% below 20-day average weakens conviction.
Revenue and equity rising, but gross margin -1.11 pp and current ratio -0.17 since earliest quarter; capex elevated at $115.9B annually while cash & ST investments down 24.7%.
Mixed signals: revenue and equity are rising while operating margins and liquidity are declining; technical momentum is neutral with price near the 20-day SMA but MACD below signal line.
Detailed AI Fundamental Analysis
Business Snapshot
- Microsoft Corp. (NASDAQ: MSFT) is a US-listed common stock in USD, matched to SEC CIK 0000789019.
- The supplied payload does not include a sector or industry classification.
- Current price: $495.63. The stock gained 4.34% across the supplied 200 daily bars, from an opening value of $475.00 to the latest close.
- Fundamental data depicts a large, highly profitable company with substantial equity, positive free cash flow, and low reported debt relative to equity.
- Valuation multiples, analyst targets, earnings guidance, segment results, and forward estimates were not provided.
Financial Trends
- Revenue trajectory: Quarterly revenue rose from $77.673B on 2025-09-30 to $81.273B on 2025-12-31, an increase of $3.600B or 4.6%. It then increased to $82.886B on 2026-03-31, up $1.613B or 2.0% sequentially. The latest 10-K reports $331.839B, but this is a full-year figure and is not directly comparable with the quarterly amounts. On a quarterly basis, revenue growth accelerated initially and then decelerated.
- Gross margin: Gross margin declined from 69.05% to 68.04% in the next period, down 1.01 percentage points, then fell to 67.63%, down another 0.41 points. It recovered modestly to 67.94% in the latest period, up 0.31 points from the prior quarter, but remained 1.11 points below the earliest supplied quarter.
- Operating margin: Operating margin moved from 48.87% to 47.09%, a 1.78-point decline, then to 46.33%, down 0.76 points. It improved slightly to 46.78%, up 0.45 points sequentially, but was still 2.09 points below 2025-09-30. This indicates margin compression followed by a modest stabilization.
- Net margin: Net margin was volatile: 35.72%, then 47.32%, then 38.34%, and latest 40.31%. The latest margin improved 1.97 points from the prior quarter but remained 4.59 points above the earliest supplied period. Net-income comparisons should be treated cautiously because the quarterly figures fluctuate substantially.
- Free cash flow: FCF declined from $25.663B to $5.882B, a drop of $19.781B or 77.1%, before recovering to $15.803B, up $9.921B or 168.7% sequentially. The latest reported figure was $66.987B, but it is presented with the annual 10-K period and is not directly comparable to the quarterly FCF figures. The quarterly trend shows a sharp trough followed by recovery, while the annual figure indicates substantially stronger cumulative cash generation.
- Capital expenditures: Quarterly capex increased from $19.394B to $29.876B, then $30.876B, showing elevated investment. The latest annual figure was $115.948B. Capex growth is a key reason to monitor whether cash-flow expansion keeps pace with investment.
- Balance-sheet trajectory: Total assets increased every period, from $636.351B to $665.302B, $694.228B, and $758.376B. Shareholders’ equity also rose from $363.076B to $442.387B, a gain of $79.311B or 21.8% across the supplied periods.
- Debt and liquidity: Long-term debt declined from $35.376B to $31.067B, down $4.309B or 12.2%. Debt/equity improved steadily from 0.10 to 0.07. However, the current ratio declined from 1.40 to 1.23, and working capital fell from $54.070B to $38.885B, indicating that current liabilities grew faster than current assets.
- Cash position: Cash and short-term investments decreased from $102.012B to $76.843B, a decline of $25.169B or 24.7%. Cash and equivalents decreased from $28.849B to $20.935B, despite growth in assets and equity.
Financial Health
- The latest period shows strong absolute profitability: $155.237B operating income, $133.749B net income, and $66.987B FCF as reported for the 2026-06-30 10-K period.
- The trend is mixed rather than uniformly improving. Quarterly revenue continued to grow, but operating and gross margins remain below the earliest supplied quarter. The latest sequential margin rebound is constructive, yet modest.
- Balance-sheet leverage appears conservative: debt/equity improved from 0.10 to 0.07, while long-term debt declined by $4.309B across the four periods.
- Liquidity has weakened: the current ratio fell 0.17 points from 1.40 to 1.23, working capital contracted by $15.185B, and cash plus short-term investments fell $25.169B.
- Investment intensity is high. Annual capex of $115.948B and negative investing cash flow of $139.500B highlight substantial capital deployment. The key long-term question is whether this investment produces sustained revenue, margin, and FCF growth; the supplied data does not include forward guidance or returns on investment.
- Shares outstanding were broadly stable, declining from 7.434B to 7.427B, a reduction of approximately 7M shares or 0.1%.
Insider Activity
- Insider sentiment is classified as Neutral (0) for 2026-06-14 through 2026-09-12.
- The dataset reports $0 of buys, $0 of sells, and $0 net activity across 12 parsed filings.
- Eleven listed transactions on 2026-09-10 are recorded as buys at $0, involving small fractional quantities. Because the reported transaction value and price are zero, these entries do not provide evidence of meaningful open-market insider buying.
- One additional transaction is listed without transaction details. Overall, the supplied insider data is not a strong directional signal.
Multi-Timeframe Technical Context
- Only the 1D timeframe was provided; intraday minute and hourly data are unavailable, so ultra-short and short-horizon conclusions are lower confidence.
- Ultra-short, minutes: No 1-minute or intraday candle data is available. The daily ATR is $10.06, indicating that daily volatility is material, but it cannot reliably define minute-level trade ranges.
- Short, hours to days: Price at $495.63 is slightly above the 20-day SMA of $494.43 and near the 12-day EMA of $496.02. It remains above the 26-day EMA of $485.85, 50-day EMA of $465.42, and 50-day SMA of $453.67, showing a broadly constructive daily trend.
- RSI-14 is 57.49 and RSI-21 is 51.42. Both are below overbought territory, suggesting positive but not stretched momentum.
- MACD is 10.1696, below its 14.0055 signal line, a bearish momentum configuration despite the price remaining above key moving averages.
- Price is below the Bollinger upper band at $513.95 and above the middle band at $494.43. This places the stock near the center-to-upper portion of its recent daily range rather than at an extreme.
- Current volume of approximately 14.5M is below the 20-day average of approximately 20.8M, or about 30.2% lower. The latest move therefore lacks confirmation from above-average volume in the supplied data.
- Long, weeks to months: The price is above the 50-day and 200-day averages, with the 200-day SMA at $431.26, supporting a long-term bullish trend structure. However, weakening operating margins, lower liquidity, high capex, and MACD below its signal line are risks to monitor.
Bull / Bear Cases
-
Short-term bull case:
- Price holds above the $494.43 middle Bollinger band and 20-day SMA.
- A move through the $513.95 upper Bollinger band, followed by stronger volume, would suggest renewed upside momentum.
- RSI remains constructive without reaching overbought levels, while price is still above the 26-day, 50-day, and 200-day trend measures.
-
Short-term bear case:
- MACD remains below its signal line, and current volume is about 30% below its 20-day average, weakening confirmation of the recent advance.
- A close below approximately $494.43 could expose the $485.85 26-day EMA and then the $474.92 lower Bollinger band.
- A break below the lower band would weaken the short-term trend and raise the probability of a deeper pullback toward the 50-day averages.
-
Long-term bull case:
- Revenue has continued to rise sequentially across the supplied quarterly periods.
- The latest reported annual results show substantial operating income, net income, and FCF.
- Equity expanded by 21.8%, debt/equity improved from 0.10 to 0.07, and long-term debt declined, supporting balance-sheet resilience.
- Quarterly FCF recovered sharply after its prior-period trough, although the latest annual and quarterly figures are not directly comparable.
-
Long-term bear case:
- Gross margin is down 1.11 percentage points and operating margin down 2.09 points versus the earliest supplied quarter.
- Capex has risen sharply, reaching $115.948B on the latest annual report, while cash and short-term investments declined 24.7% across the supplied balance-sheet periods.
- The current ratio fell from 1.40 to 1.23, and working capital declined by $15.185B.
- The supplied data contains no valuation, guidance, segment outlook, or analyst estimates, so it cannot establish whether the current price adequately compensates investors for these risks.
Key Levels & Triggers
- Immediate pivot: Approximately $494.43, represented by both the 20-day SMA and Bollinger middle band.
- Near-term support: $485.85, the 26-day EMA.
- Secondary support: $474.92, the lower Bollinger band.
- Trend support: $465.42, the 50-day EMA, followed by $453.67, the 50-day SMA.
- Major long-term trend reference: $431.26, the 200-day SMA.
- Upside trigger: $513.95, the upper Bollinger band. A sustained break above this level with volume above the approximately 20.8M 20-day average would provide stronger technical confirmation.
- Downside trigger: A decisive close below $494.43, especially if followed by a break of $485.85, would signal weakening short-term momentum.
- Fundamental triggers to monitor: further quarterly revenue growth, stabilization or renewed compression in gross and operating margins, FCF after elevated capex, changes in cash and short-term investments, and any deterioration in the current ratio.
- Data limitation: No intraday timeframes, valuation metrics, guidance, analyst targets, or detailed segment fundamentals were provided.